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Protozoan microtubules are sensitive to disruption by dinitroanilines, compounds that kill intracellular Toxoplasma
gondii parasites without affecting microtubules in vertebrate host cells. We previously isolated a number of resistant
Toxoplasma lines that harbor mutations to the ␣1-tubulin gene. Some of the mutations are localized in or near the M and
N loops, domains that coordinate lateral interactions between protofilaments. Other resistance mutations map to a
computationally identified binding site beneath the N loop. Allelic replacement of wild-type ␣1-tubulin with the
individual mutations is sufficient to confer dinitroaniline resistance. Some mutations seem to increase microtubule length,
suggesting that they increase subunit affinity. All mutations are associated with replication defects that decrease parasite
viability. When parasites bearing the N loop mutation Phe52Tyr are grown without dinitroaniline selection, they
spontaneously acquired secondary mutations in the M loop (Ala273Val) or in an ␣-tubulin–specific insert that stabilizes
the M loop (Asp367Val). Parasites with the double mutations have both reduced resistance and diminished incidence of
replication defects, suggesting that the secondary mutations decrease protofilament affinity to increase parasite fitness.

INTRODUCTION
Microtubules are essential components of diverse structures
in eukaryotic cells. These structures include spindles used
for chromosome segregation, flagellar/ciliary axonemes
used for motility, and cytoplasmic microtubule arrays used
as tracks for vesicle transport (Nogales, 2000). Microtubules
are built by the polymerization of ␣-␤-tubulin heterodimers,
and they typically contain 13 protofilaments, a substructure
formed by the longitudinal head-to-tail association of the
heterodimers. The lateral association of protofilaments
forms a microtubule, which consists of a 24-nm-wide cylinder with a hollow lumen (Downing and Nogales, 1998a,b; Li
et al., 2002).
Because ␣- and ␤-tubulins are ancestrally related proteins,
they contain many domains that have similar structure and
function, such as the M and N loops, which coordinate
contacts between adjacent protofilaments (Downing, 2000;
Lowe et al., 2001; Li et al., 2002). However, ␣- and ␤-tubulins
also have important differences. For example, although both
␣- and ␤-tubulins bind to guanosine triphosphate (GTP),
only the ␤-tubulin GTP is hydrolyzed (Davis et al., 1994;
Sage et al., 1995; Anders and Botstein, 2001; Dougherty et al.,
2001). Polymerization-dependent ␤-tubulin GTP hydrolysis
is stimulated by a GTPase-activating domain of ␣-tubulin
from the adjacent dimer within the protofilament. When
GTP is hydrolyzed, dimers undergo a conformation change
This article was published online ahead of print in MBC in Press
(http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E07– 04 – 0379)
on September 19, 2007.
†

These authors contributed equally to this work.

Address correspondence to: Naomi Morrissette (nmorriss@uci.edu).
© 2007 by The American Society for Cell Biology

that promotes microtubule disassembly (Nicholson et al.,
1999; Nogales et al., 2003; Nogales and Wang, 2006a,b).
Appropriate microtubule disassembly is as essential as assembly to the appropriate function of tubulin. Expression of
mutant ␣-tubulin genes that lack a functional GTPase activation domain causes a lethal phenotype in budding yeast
associated with extraordinarily long and stable microtubules
(Anders and Botstein, 2001). One of the traits that distinguishes ␣-tubulins from ␤-tubulins is a conserved eightamino acid insert (Thr, Val, Val, Pro, Gly, Gly, Asp, Leu)
beginning at residue 360 (361 in the Toxoplasma sequence)
(Nogales et al., 1998). The structure of stabilized zinc sheets
demonstrated that Taxol (paclitaxel) occupies the same region in ␤-tubulin as the insert does in ␣-tubulin (Snyder et
al., 2001). These results indicate that the ␣-tubulin M loop
has greater protofilament stability than the ␤-tubulin M loop
and that by stabilizing the ␤-tubulin loop contacts, microtubules are stabilized.
A diverse array of compounds affect microtubule function
by shifting the normal equilibrium between tubulin dimers
and polymers to destabilize (e.g., colchicines) or stabilize
(e.g., paclitaxel) microtubules (Jordan et al., 1998). Because
the balanced assembly and disassembly of microtubules is a
critically important part of microtubule function, compounds that upset the equilibrium between heterodimer
subunits and polymerized microtubules are toxic. Therapeutic strategies have exploited this feature to inhibit the proliferation of fast-growing cancer cells. Other tubulin-binding
compounds are used as antiparasitic and antifungal agents
and as herbicides. With the exception of the dinitroanilines
and peloruside A, all characterized compounds that alter
tubulin equilibrium bind to and act on ␤-tubulin (Morrissette et
al., 2004; Pineda et al., 2004; Jimenez-Barbero et al., 2006;
Mitra and Sept, 2006). Because ␣-tubulin ligands such as the
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dinitroanilines and peloruside A are only recently identified,
they are likely to be important tools for establishing the role
of ␣-tubulin in the tubulin dimer, much as other tubulin
binding drugs have helped clarify how the ␤-tubulin monomer functions.
The activity of dinitroanilines, informally called the “yellow” herbicides, was first reported by scientists from Eli
Lilly in 1960 (Alder et al., 1960). Dinitroanilines (oryzalin,
trifluralin, and ethafluralin) selectively disrupt plant and
protozoan microtubules (Traub-Cseko et al., 2001). These
compounds bind to sensitive (plant and protozoan) but not
resistant (vertebrate and fungal) tubulins. Protozoan parasites, including those broadly grouped as kinetoplastids,
apicomplexans and amoeba, are sensitive to dinitroanilines,
which inhibit their replication (Chan and Fong, 1990; Kaidoh
et al., 1995; Stokkermans et al., 1996; Bogitsh et al., 1999;
Werbovetz et al., 1999; Makioka et al., 2000a,b; Traub-Cseko
et al., 2001; Bhattacharya et al., 2002, 2004; Morrissette and
Sibley, 2002; Werbovetz et al., 2003). Given that the dinitroanilines do not disrupt vertebrate tubulins, dinitroaniline activity is of particular interest for the development of new
antiparasitic drugs. We are specifically interested in understanding the action of dinitroanilines on apicomplexan parasites such as Toxoplasma gondii.
Toxoplasma gondii is a member of the Apicomplexa, a
phylum of protozoa that are obligate intracellular parasites
(Levene, 1988). Parasites released by host cell lysis must
rapidly invade new host cells to stay alive. Despite these
stringent growth requirements, apicomplexans are widespread and damaging pathogens with profound direct and
indirect impacts on human welfare. Human infection by T.
gondii can cause life-threatening illness in immunocompromised individuals and birth defects or miscarriage during
fetal infection (Black and Boothroyd, 2000). Other apicomplexans include Plasmodium (agent of malaria) and Cryptosporidium (an opportunistic pathogen), which are parasites
of considerable medical importance, and Theileria and Eimeria, animal pathogens with extensive impact on food production (Levene, 1988).
Apicomplexans are named for their polarized apex that
contains several unique organelles that coordinate invasion
of host cells. Apicomplexan parasites are surrounded by the
pellicle, a composite structure formed by the association of
the plasma membrane with the inner membrane complex,
an assemblage of flattened vesicles. There are two populations of microtubules in the invasive stages of apicomplexan
parasites: subpellicular microtubules and spindle microtubules (Morrissette and Sibley, 2002). Subpellicular microtubules are nondynamic; they maintain both apical polarity
and the characteristic crescent shape of the parasite by interacting with the pellicle. Spindle microtubules form an
intranuclear spindle to coordinate chromosome segregation.
Both populations are critically important to parasite survival
and replication. Wild-type Toxoplasma parasites are resistant
to ⬍0.2 M oryzalin. This value is difficult to measure
directly, because parasites in oryzalin continue to undergo
protein and DNA synthesis in the absence of microtubule
function, making it impossible to measure IC50 values by
radiolabel incorporation (Stokkermans et al., 1996). Using
drug washout and plaquing values, the approximate IC50
value is 0.1 M oryzalin, and using morphology (round
rather than elongated parasites), parasites begin to round up
by ⬃0.2 M oryzalin (Stokkermans et al., 1996; Morrissette
and Sibley, 2002).
In previous work, we used genetic analysis of oryzalinresistant Toxoplasma lines in combination with computational methods to identify a binding site and mode of action
4712

for the dinitroanilines (Morrissette et al., 2004). Additional
computational analysis extended these studies to include the
interaction of the dinitroanilines oryzalin, trifluralin, and
GB-II-5 with Toxoplasma, Leishmania, Plasmodium, and bovine
tubulins (Mitra and Sept, 2006). The refined dinitroaniline
binding site is located on Toxoplasma, Leishmania, and Plasmodium ␣-tubulins beneath the N loop, and it is formed by
residues of strand S1 (Arg2, Glu3, Val4, Ile5, Ser6), helix H1
(Cys20, Trp21, Phe24), the N/H1-S2 loop (His28, Met36,
Asp39, Lys40, Thr41, Ile42, Asp47, Pro63, Arg64), strand S2
(Cys65), strand S4 (Leu136), helix H7 (Ile235, Ser236, Thr239,
Ala240, Ser 241), and the T7 loop (Arg243, Phe244, Asp245).
Analysis of vertebrate ␣-tubulin indicates that dinitroanilines have nonspecific, low-affinity interactions and no consensus binding site, consistent with in vivo and in vitro
observations that dinitroanilines do not bind to vertebrate
tubulin or disrupt vertebrate microtubules (Morejohn et al.,
1987; Hugdahl and Morejohn, 1993; Murthy et al., 1994).
When molecular dynamics analysis is used to compare ␣-tubulin mobility in the presence or absence of bound drug,
these simulations suggest that dinitroaniline binding profoundly limits flexibility of the ␣-tubulin N loop, which is
drawn in toward the core of the tubulin dimer (Mitra and
Sept, 2006). We hypothesize that when dinitroanilines bind
tubulin, the N loop is less able to make contacts with the M
loop of the dimer in the adjacent subunit. This prevents
tubulin polymerization, destabilizes preexisting microtubules, or both.
In the work presented here, we have generated Toxoplasma
parasites that bear homologous integrations of many of the
␣-tubulin point mutations associated with dinitroaniline resistance. We selected the mutations to test in this study by
their predicted mechanism of action: some mutations are
expected to stabilize microtubules (a GTPase-activating domain mutant and N and M loop mutants), whereas others
are anticipated to act by altering the dinitroaniline binding
site to lower its affinity for oryzalin. We have characterized
the advantageous features of these mutations (dinitroaniline
resistance) as well as deleterious aspects (increased replication defects) to conclude that drug resistance has a fitness
cost in T. gondii.
MATERIALS AND METHODS
Culture of Toxoplasma Lines
Toxoplasma tachyzoites (RH strain) were propagated in human foreskin fibroblast (HFF) cells in DMEM with 10% fetal bovine serum as described previously (Roos et al., 1994). Oryzalin (Riedel-deHaën, Seelze, Germany) stock
solutions were made up in dimethyl sulfoxide. Oryzalin-resistant parasite
lines were isolated after ethyl-nitrosourea mutagenesis by selection in 0.5 or
2.5 M oryzalin as described previously (Morrissette et al., 2004).

Analysis of ␣1-Tubulin Point Mutations
The ␣1-tubulin gene was amplified from genomic DNA isolated from individual oryzalin-resistant parasites by using thermal cycling with primers
GAGTCTCGTAGAGAACAAGC (5⬘ untranslated region [UTR]) and CGTTTATACCTTCACCTTTTC (3⬘ UTR). The amplified 2.3-kb fragment was sequenced and analyzed using Sequencher software (Gene Codes, Ann Arbor,
MI) to identify point mutations in the coding sequence of the ␣1-tubulin gene.
Primers and methods to sequence the ␣1-tubulin gene constructs are as
described previously (Morrissette et al., 2004). Similar sequencing analysis
indicated that none of the resistant lines had mutations in the ␤1-tubulin gene.
We also analyzed the sequences of two recently identified additional Toxoplasma ␣-tubulin genes (␣2-tubulin and ␣3-tubulin), but we did not identify
any mutations associated with these genes in resistant parasites (data not
shown).

Creation of ␣-Tubulin Point Mutations
The QuikChange kit (Stratagene, La Jolla, CA) was used to modify a previously generated construct containing a 2.3-kb insert of the Toxoplasma ␣1tubulin gene where a unique XbaI site in the second intron of ␣1-tubulin was

Molecular Biology of the Cell

Dinitroaniline Resistance Mutations

Table 1. Primers used to introduce tubulin mutations
Mutation
Val4Leu
Ser6Ile
Phe24His
His28Gln
Phe49Cys
Phe52Ile
Phe52Leu
Phe52Tyr
Leu136Phe
Ile235Leu
Ile235Thr
Ile235Val
Thr239Ile
Arg243Cys
Arg243Ser
Val252Leu
Met268Thr
Ala273Val
Ile275Thr
Ala295Val
Met301Thr
Asp367Val
Ser187Ala
Ala278Thr
Ser287Thr
Met302Leu
Met302Phe

Location

Primer

Binding site
Binding site
Binding site
N loop/binding site
N loop
N loop
N loop
N loop
Binding site
Binding site
Binding site
Binding site
Binding site
Binding site
Bnding site
GAP domain
Near M loop
M loop (secondary)
M loop
Near M loop
Near M loop
␣-Insert (secondary)
Fish
Fish, M loop
Fish, M loop
Fish, near M loop
Fish, near M loop

CGACAAAATGAGAGAGCTTATCAGCATCCACGTCGGCCAGGCC
CGACAAAATGAGAGAGGTTATCATCATCCACGTCGGCCAGGCCGG
GTTTTCTCTCCTTCTTTTAGGGAGCTCCACTGCCTGGAACATGG
GGAGCTCTTCTGCCTGGAACAAGGTATCCAGCCG
GGTGGTGACGACGCCTGCAACACCTTCTTTTCCGAGACAGGC
GACGACGCCTTCAACACCATCTTTTCCGAGACAG
GACGACGCCTTCAACACCCTCTTTTCCGAGACAG
CGACGCCTTCAACACCTACTTTTCCGAGACAGG
GCACTGGTCTCCAGGGTTTCTTCATGTTCAACGCCGTCGGC
CCTGAACAGACTGATTGCCCAGGTCCTCTCCTCCCTGACCGCG
CCTGAACAGACTGATTGCCCAGGTCACCTCCTCCCTGACCGCG
CCTGAACAGACTGATTGCCCAGGTCGTCTCCTCCCTGACCGCG
GCCCAGGTCATCTCCTCCCTGATCGCGTCTCTCCG
CGCGTCTCTCTGTTTCGATGGTGCGCTCAACGTCGACG
CGCGTCTCTCAGTTTCGATGGTGCGCTCAACGTCGACG
GGTGCGCTCAACGTCGACCTGACTGAGTTCCAGACCAACTTGG
CTACCCACGCATTCACTTCACGCTCTCATCGTATGCG
GCTCTCATCGTATGTGCCCATCATCAGCGCAGAGAAGG
CTCATCGTATGCGCCCACCATCAGCGCAGAGAAG
CTGAGATCACCAACTCGGTTTTCGAGCCCGC
CGAGCCCGCGAGCACGATGGCCAAGTGTGATCC
CCCACTGTGGTTCCTGGTGGTGTCTTGGCCAAGGTCATGCGCGCC
GCAGTTGTGGAACCGTACAACGCCGTCCTTTCCACTCACTCTCTGTTGG
CGTATGCGCCCATCATCAGCACAGAGAAGGCGTACCACGAGCAG
GGCGTACCACGAGCAGTTGACTGTCGCTGAGATCACC
CGAGCCCGCGAGCATGTTGGCCAAGTGTGATCCTCG
CGAGCCCGCGAGCATGTTCGCCAAGTGTGATCCTCG

replaced with a novel BamHI site. For this study, 21 single point mutations
(Val4Leu, Ser6Ile, Phe24His, His28Gln, Phe49Cys, Phe52Ile, Phe52Leu, Phe52Tyr,
Leu136Phe, Ile235Leu, Ile235Thr, Ile235Val, Arg243Cys, Arg243Ser, Val252Leu,
Met268Thr, Ala273Val, Ile275Thr, Ala295Val, Met301Thr, and Asp367Val) and
two double mutations (Phe52Tyr/Ala273Val and Phe52Tyr/Asp367Val) were
introduced into the Toxoplasma ␣1-tubulin gene. We also introduced five point
mutations that are observed as differences in the ␣-tubulin genes of Antarctic fish
(Ser187Ala, Ala278Thr, Ser287Thr, Met302Leu, and Met302Phe) into the Toxoplasma ␣1-tubulin gene (Detrich et al., 2000). The mutagenesis primers used to
generate these mutant tubulins are listed in Table 1. All ␣-tubulin constructs were
verified by sequencing as described previously (Morrissette et al., 2004).

Transformation, Selection, and Analysis of
Oryzalin-resistant Transformants
Approximately 107 RH strain tachyzoites were transformed with ⬃8 g of a
linearized construct, selected in 0.5 M oryzalin, and single cell cloned as
described previously (Morrissette et al., 2004). Individual clones were assayed
for homologous integration of the point mutations by amplification of the
␣1-tubulin gene followed by restriction enzyme analysis of the amplified
insert by using XbaI or BamHI enzymes. Parasites harboring an allelic replacement of each point mutation construct were assayed for their drug
resistance using increasing concentrations of oryzalin and scoring for changes
in morphology as described previously (Morrissette et al., 2004). In our
previous study, we isolated and characterized individual clones from a single
transfection and selection of 107 parasites. Because it is possible that these
clones are siblings rather than independent lines, we have altered our approach during this study to isolate allelic replacements from parasites derived
from more than one independent transfection and selection. Parasites bearing
allelic replacements of the mutations His28Gln, Thr239Ile, Arg243Ser, and
Arg243Cys obtained from two independent transfections and selections
yielded consistent results in this study.

Immunofluorescence of Parasites
Intracellular parasites on 12-mm circular glass coverslips were fixed, permeabilized, and stained as described previously (Morrissette and Sibley, 2002).
They were mounted in VECTASHIELD mounting media with 4,6-diamidino2-phenylindole (Vector Laboratories, Burlingame, CA). Images of newly invaded parasites stained with a Toxoplasma specific anti-␤-tubulin antibody
(Morrissette and Sibley, 2002) and an Alexa 488 secondary antibody (Invitrogen, Carlsbad, CA) were collected on a Zeiss Axioskop using the AxioVision
camera and software (Carl Zeiss, Thornwood, NY). Z-series images were
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processed using Zeiss deconvolution software and images were exported and
manipulated in Photoshop 8.0 (Adobe Systems, Mountain View, CA).

Quantification of Replication Defects
Toxoplasma were passed into HFF cells without oryzalin and allowed to grow
until the host cell monolayer was completely lysed. Extracellular wild-type
RH parasites (the parental strain) and parasites bearing homologous integrations of the dinitroaniline resistance mutations were viewed in suspension in
MatTek dishes with a coverslip inset by using a 63⫻ phase-contrast lens on a
Zeiss Axioskop microscope. Images of random fields were captured as tif files
and scored by counting. Three independent samples were counted for each
cell line. In order not to under-represent the aberrant forms, we counted the
number of apical regions to establish total possible parasites lost from the
parasite population through replication defects. All aberrant forms were
counted together.

RESULTS
We have characterized a diverse group of point mutations in
␣1-tubulin that are associated with oryzalin resistance in T.
gondii (currently 35 different mutations at 25 locations in
␣1-tubulin). When these mutations are mapped onto a
model of Toxoplasma ␣1-tubulin, many are located in regions
that suggest that two mechanisms confer resistance in most
cases: mutations that increase dimer– dimer affinity compensate for dinitroaniline disruption of microtubules and mutations that decrease dimer affinity for oryzalin alter the
dinitroaniline binding site (Figure 1). We have used an established method to introduce point mutations from these
regions into wild-type Toxoplasma by homologous recombination (Figure 2A). These ␣1-tubulin point mutations are
either predicted to increase microtubule stability (mutations
located in the N loop, the M loop, and the GTPase-activating
domain of ␣-tubulin) or to affect the dinitroaniline binding
site (Figure 1). In most cases, the point mutations confer low
levels of oryzalin resistance (0.5–7.5 M). However, four
mutations confer resistance to significantly higher concen4713
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Figure 1. A model of the structure of Toxoplasma ␣1-tubulin with bound oryzalin (orange) based on previous molecular dynamics
and docking results (Morrissette et al., 2004).
Binding site residues that occur as point mutants are colored green. The N and M loops are
colored mauve and the GTPase-activating domain is highlighted in yellow. (A) The N loop
residues His28, Phe49, and Phe52 are mutated
in dinitroaniline-resistant Toxoplasma lines. (B)
The M loop contains Ala273 and Ile275, which
are identified in dinitroaniline resistant ␣-tubulin genes and other mutations at Met268,
Ala295, and Met301 are nearby the M loop.
The Ala273 mutation is a second site mutation
rather than a resistance mutation (see below).
(C) The GTPase activating domain of ␣-tubulin (yellow) contains a resistance mutation at
Val252. Residues Asp251 and Glu254 (asterisks) were shown previously to be essential
residues for activating the GTPase of ␤-tubulin (Anders and Botstein, 2001). (D) The dinitroaniline binding site is defined by several
residues, including 11 that are mutated in resistant parasites. These residues are Val4, Ser6,
Phe24, His28 (also in the N loop), Leu136,
Ile235, Thr239, and Arg243. (E) The entire
␣-tubulin subunit is displayed with the adjacent ␣-␤ heterodimer contact area in the foreground. The ␤-tubulin subunit of the heterodimer (data not shown) would be behind
the ␣-tubulin structure.

trations of oryzalin. Parasites with the Leu136Phe mutation
are resistant to 36 M oryzalin, and those with the Thr239Ile,
Val252Leu, or Arg243Ser mutations are resistant to ⬃40 M
oryzalin (Figure 2B).
In the absence of oryzalin, some of the tubulin mutations
result in Toxoplasma that seem to have a thinner and elongated
shape relative to the dinitroaniline-sensitive parental strain.
This is most obvious in Toxoplasma bearing a homologous
integration of the N loop mutation His28Gln (Figure 3). Threedimensional reconstructions of Toxoplasma subpellicular microtubules by using deconvolution microscopy suggest that microtubule length is increased in parasites with the His28Gln
point mutation (Figure 3, C–E). This increased length is likely
to result from a shift in the equilibrium between tubulin dimers
and microtubule polymers.
To test whether ␣-tubulin amino acid substitutions that are
thought to stabilize microtubules in the Antarctic fish Chionodraco rastrospinosus are able to confer resistance to dinitroanilines, we introduced directed changes to Toxoplasma ␣1-tubulin
to make single point mutations at Ser187Ala, Ala278Thr,
Ser287Thr, Met302Leu, and Met302Phe. Although some of the
Antarctic fish substitutions are very similar to the dinitroaniline resistance mutations (the oryzalin resistance mutation
Met301Thr is adjacent to the fish mutations Met302Leu and
Met302Phe), we did not recover parasites that had integrated
the altered tubulin after selection in oryzalin. Because we only
select for ␣1-tubulin gene integrations with dinitroanilines, we
cannot distinguish whether these substitutions do not stabilize
Toxoplasma microtubules to confer resistance or whether the
4714

resulting microtubules are toxic because they are too stable
when expressed in Toxoplasma.
Toxoplasma replicates by endodyogeny, a process of internal budding. We observed an increased proportion of abnormal Toxoplasma “monsters” that are a consequence of
aberrant replication (Figure 4). In many cases, these monsters can be attributed to a failure of mutant parasites to
synchronize nuclear division (which requires spindle microtubules) and the formation of daughter buds (which requires
subpellicular microtubules) during endodyogeny. Toxoplasma actively invades host cells by using actin-based motility in conjunction with a moving junction that forms between the parasite and the host plasma membrane (Soldati
and Meissner, 2004). Parasites that lack a rigid elongated
crescent shape are incapable of invading host cells (Stokkermans et al., 1996; Shaw et al., 2000; Morrissette and Sibley,
2002; Morrissette et al., 2004). Because abnormal forms that
fail to complete scission (examples 4 –11 in Figure 4C) cannot
invade new host cells, these are nonviable organisms. There
may also be other defective parasites that have lost single
chromosomes but seem normal at the level of the light
microscope. We attempted to evaluate the frequency of
chromosome missegregation using flow cytometry of intracellular (released by syringe passage) parasites stained with
SYTOX-green. Toxoplasma has 14 chromosomes; therefore,
the loss of a single chromosome would be associated with an
⬃7% decrease in staining intensity for a small subpopulation
of parasites associated with the 1N peak. We were not able
to resolve any reproducible differences in DNA content
Molecular Biology of the Cell

Dinitroaniline Resistance Mutations

Figure 2. (A) Diagram of the exon–intron
structure of ␣1-tubulin used for the allelic replacement strategy. Endogenous (wild-type)
␣1-tubulin has a unique XbaI restriction site in
intron 2. The transgene was altered to ablate
the XbaI site and to introduce a unique BamHI
site in intron 2. The individual point mutations were introduced in the transgene construct and electroporated into Toxoplasma. Parasites with a homologous integration of the
transgene are identified by conversion of the
XbaI restriction site to a BamHI site. (B)
Oryzalin resistance of Toxoplasma with allelic
integration of the ␣1-tubulin gene containing
the individual point mutations in the binding
site (BS), N loop (NL), M loop (ML), and GTPaseactivating domain (GD). Resistance conferred
by the predicted binding site mutation
Thr239Ile was previously reported to be 5 M,
which is in error. We have generated two new
independent integrations of the Thr239Ile construct that have resistance to 41 M oryzalin,
as illustrated here.

given the variation associated with this assay and the resolution required for this measurement (data not shown). We
demonstrated previously that anucleate Toxoplasma (example 2 in Figure 4C) can invade host cells, but obviously
cannot proliferate in the absence of a nuclear genome (Morrissette and Sibley, 2002). Similarly, parasites with inappropriate chromosome content may seem normal and reinvade
host cells, but they will be unable to grow and replicate.
When the relative occurrence of grossly abnormal extracellular parasites is quantified for the parental Toxoplasma
strain and parasite lines bearing homologous integrations of
the ␣1-tubulin point mutations, it is clear that all of the point
mutations are associated with some degree of increased
rates of replication defects (Figure 5). Extracellular RH (parental strain) Toxoplasma have ⬃4% of parasites with overt
replication defects. Enhanced replication defect rates are
particularly obvious in N loop mutants, which have 10 –13%
of extracellular parasites that are grossly altered and incapable of continued cycles of invasion and replication. The
binding site mutation Arg243Ser has high oryzalin resistance (41 M) tempered by an ⬃12% rate of replication
defects.
Parasites bearing the N loop mutation Phe52Tyr have
resistance to 7 M oryzalin. When this strain was grown in
the absence of oryzalin, it spontaneously acquired second
site mutations at Ala273Val or Asp367Val. Our gene replacement method is limited to introducing ␣1-tubulin transgenes
that can be selected for by oryzalin resistance. Despite several attempts to isolate parasite lines bearing Ala273Val and
Asp367Val as single mutations to the ␣1-tubulin gene, we
were unable to obtain them, suggesting that they do not
confer resistance. When combined with Phe52Tyr, the
Ala273Val and Asp367Val mutations were easily isolated as
homologous integrations, and parasite lines with the double
Vol. 18, December 2007

mutations (Phe52Tyr/Ala273Val and Phe52Tyr/Asp367Val)
showed lower resistance than that of parasites with
Phe52Tyr mutation alone. We have, therefore, concluded
that the Ala273Val and Asp367Val mutations do not confer
oryzalin resistance alone, and when combined with the
Phe52Tyr mutation, the second site mutations decrease resistance to 2.8 and 3.3 M oryzalin, respectively (Figure 6A).
The degree of replication defects in the single mutation
Phe52Tyr (⬃13%) is higher than that of the double mutations (⬃6 and 5%), suggesting that in the absence of oryzalin, replication defects are sufficiently deleterious to select
for spontaneous secondary mutations that correct this disadvantageous condition (Figure 6B). The location of the
second site mutations is consistent with a role in decreased
protofilament interactions. The Ala273Val mutation is in the
M loop and the Asp367Val mutation is in an ␣-tubulin insert
that stabilizes the ␣-tubulin M loop. The substitution of Val
for Asp at this location disrupts a salt bridge between
Asp367 and Arg229, presumably destabilizing the insert,
which in turn destabilizes the M loop protofilament contact
(Figure 6C).

DISCUSSION
Dinitroaniline resistance mutations have been reported in
the unicellular green alga Chlamydomonas reinhardtii, in
higher plants such as Eleusine indica (goosegrass) and Setaria
viridis (green foxtail), and in the protozoans T. gondii and
Tetrahymena thermophila (Schibler and Huang, 1991; James et
al., 1993; Gaertig et al., 1994; Anthony et al., 1998; Yamamoto
et al., 1998; Delye et al., 2004). In some cases, such as
Thr239Ile and Leu136Phe, the same ␣-tubulin mutation has
been identified in dinitroaniline-resistant Toxoplasma, Eleus4715
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Figure 3. Phase-contrast microscopy of extracellular wild-type (A)
and His28Gln mutant parasites (B) illustrates that Toxoplasma expressing the His28Gln mutation are thinner and longer and they
show an increased frequency of septation defects. (C–E) Projections
of wild-type (C) and His28Gln mutant parasites (E) indicate that
His28Gln mutant parasites have longer microtubules. These threedimensional projections were created by collecting Z-series images
of newly invaded parasites stained with a Toxoplasma-specific tubulin antibody. The images were processed with Zeiss deconvolution
software. An overlay of the wild-type parasite projection (green)
on the His28Gln mutant parasite projection (red) illustrates the
increased subpellicular microtubule length in the mutant parasites (D).

ine, and Setaria. In data presented here, we demonstrate that
resistance mutations identified in other species function to
confer resistance in Toxoplasma. The Met268Thr mutation
observed in Eleusine confers dinitroaniline resistance in Toxoplasma as does a Phe24His substitution that is analogous to
the Tyr24His mutation in Chlamydomonas (James et al., 1993;
Anthony et al., 1998; Yamamoto et al., 1998). However, when
we attempted to introduce substitutions that are hypothesized to confer cold stability to the microtubules of Antarctic
fish (Detrich et al., 2000), they do not confer oryzalin resistance. Because we select for transformation with dinitroanilines, we are unable to distinguish whether these substitutions do not confer dinitroaniline resistance in Toxoplasma or
whether they are lethal when expressed because the microtubules are too stable.
The observations presented in this article 1) that M and N
loop mutations have relatively low resistance and the highest incidence of replication defects and 2) that a subset of
binding site mutations have extremely high resistance are
consistent with our working model that invokes two major
mechanisms of dinitroaniline resistance. In this study, we
selected a subset of tubulin mutations to analyze from a
larger collection of substitutions conferring dinitroaniline
resistance based on the location of the altered residues in the
structure of ␣-tubulin. In previous work, we characterized
homologous integrations of five resistance mutations that
were selected from the larger set of mutations. Three of the
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previously studied mutations were distinct substitutions
(Ala, Pro, Thr) to Ser165: these mutations conferred relatively low dinitroaniline resistance (1–2 M oryzalin). Other
researchers subsequently identified Ser165Pro as an ␣-tubulin mutation associated with resistance to HTI-286 (a hemiasterlin derivative) in human carcinoma cell lines (Poruchynsky et
al., 2004). Because the hemiasterlin binding site has been
located in a distinct region of the tubulin dimer at the
␣-␤-subunit interface, predominantly in ␤-tubulin, we expect that the Ser165Pro mutation is associated with general
microtubule stability (Mitra and Sept, 2004; Ravi et al., 2005).
The other two previously studied point mutations were
Thr239Ile, which had been previously identified in dinitroaniline-resistant goosegrass and Ile231Thr, which is in the
same face of ␣-helix 7 as Thr239 (Morrissette et al., 2004). The
original Thr239Ile line did not survive freezing and we
recently discovered that in two new and independent integrations, the Thr239Ile confers resistance to 40 M oryzalin
(Figure 2). This suggests that the previous line was an incorrectly genotyped nonhomologous integration. Our corrected observation is consistent with the other data presented here that suggests that mutations to residues in the
binding site are associated with high resistance (Figure 2).
Previous researchers have demonstrated the importance
of the M and N loop residues in microtubule function and
stability by using both natural mutations and directed substitutions to these domains in ␣-tubulin. Alanine scanning
studies in budding yeast have identified ␣-tubulin N loop
mutations that are benomyl resistant, presumably due to
increased microtubule stability, or benomyl supersensitive,
presumably due to decreased microtubule stability (Richards et
al., 2000). Alanine scanning analysis also indicates that M
loop substitutions are associated with benomyl supersensitivity, revealing that these microtubules have decreased stability (Richards et al., 2000). The ␣-tubulin N loop mutation
Glu55Lys and the M loop mutation His283Tyr confer colcimid and vinblastine resistance in human cells (Hari et al.,
2003).
Dynamic instability of microtubules depends on the polymerization-stimulated hydrolysis of GTP bound to ␤-tubulin, and it is necessary for microtubule disassembly (Davis
et al., 1994; Sage et al., 1995; Anders and Botstein, 2001;
Dougherty et al., 2001). Experiments in budding yeast indicate that two residues (Asp252 and Glu255) in ␣-tubulin
activate the ␤-tubulin GTPase in the adjacent dimer (Richards et
al., 2000; Anders and Botstein, 2001). When these residues
are mutated to alanine, the resulting dimers are poisonous
and are lethal as a minor component of the total tubulin
population (Anders and Botstein, 2001). Budding yeast with
induced expression of mutant ␣-tubulins (Asp252Ala,
Glu255Ala, and Asp252Ala/Glu255Ala) have aberrant bundled microtubules. These microtubules are not dynamic, and
microtubule-disrupting drugs are incapable of disrupting
the microtubules. The dinitroaniline-resistance mutation in
Toxoplasma ␣1-tubulin at Val252Leu is not the equivalent
residue to the Asp252 residue in Saccharomyces cerevisiae. The
Toxoplasma Val252 residue is equivalent to Leu253 in yeast,
and so it is immediately adjacent to the critically important
residue (Figure 1C). We hypothesize that the Val252Leu
mutation may decrease the activity of the GTPase-activating
domain to increase microtubule stability. This mutation is
associated with very high dinitroaniline resistance, but it
does not seem to cause the parasites to have obviously
longer and more stable microtubules.
Our analysis of the effect of tubulin mutations on replication indicates that all of the resistance mutations confer
increased rates of defects to negatively influence parasite
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Figure 4. Hyperstabilized microtubules affect the fidelity of parasite replication (A) Toxoplasma parasites replicate by endodyogeny, a
process of internal budding that creates two
internal daughter parasites within a mother
parasite. This process permits an apically polarized “mother” parasite to undergo mitosis
while building two polarized daughter buds,
each consisting of inner membrane complex,
subpellicular microtubules, and apical organelles around the daughter nuclei. When
the daughter parasites are mature, they
emerge from the mother, adopting her
plasma membrane. (B) Illustration of the aberrant forms of extracellular parasites: (i)
anucleate and (ii) diploid parasites result
from completion of cytokinesis in the absence
of nuclear division; (iii) parasites that complete cytokinesis in the absence of nuclear
division can exclude nuclear material; twoheaded (iv) or multiple headed (v) parasites
result from arrest during cytokinesis in the
absence of nuclear division; (vi) and parasites
with late completion of nuclear division can
fail to complete septation (cytokinesis). (C)
Phase-contrast images of malformed extracellular parasites. The large panel shows an apparently wild-type parasite (1) next to an
anucleate parasite (2) and a grossly enlarged
parasite (3). The anucleate and enlarged parasites (2 and 3) likely result from cytokinesis without nuclear division as illustrated in B iv, which shows similar parasites jointed by incomplete
cytokinesis. Incomplete septation of one (5), two (6), three (7), or four (8 and 9) daughter buds from a residual body containing some or all nuclear
material. Parasites in 10 and 11 have completed nuclear division and daughter cell formation, but they have not completed septation.

fitness. As shown in Figure 5, substitutions predicted to
hyperstabilize microtubules (M and N loops) are generally
associated with the highest rates of replication defects. This

may be associated with defective chromosome segregation,
because previous studies have associated decreased microtubule dynamics with chromosome loss (Beinhauer et al.,

Figure 5. Quantification of gross replication defects in the individual ␣-tubulin lines. Relative proportion of replication defects in wild-type
parasites and the individual homologous integrations. The parental RH strain has ⬃4% aberrant extracellular parasites. The binding site (BS),
N loop (NL), M loop (ML) and GTPase-activating domain (GD) mutants all have some degree of increased replication defects.
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Figure 6. Dinitroaniline resistance is sufficiently deleterious that in the absence of oryzalin selection, Toxoplasma parasites harboring the
Phe52Tyr mutation acquire compensatory second site mutations at either Ala273Val (the M loop) or Asp367Val. (A) Oryzalin resistance of
the single mutant Phe52Tyr (7 M) is greater than that of the double mutants Phe52Tyr/Ala273Val (2.8 M) and Phe52Tyr/Asp367Val (3.3
M). The single substitutions Ala273Val or Asp367Val do not confer any oryzalin resistance. (B) Replication defects associated with the single
mutant Phe52Tyr are greater (⬃13%) than those in the double mutants Phe52Tyr/Ala273Val (⬃6%) and Phe52Tyr/Asp367Val (⬃5%). (C)
Substitution of Val for Asp at residue 367 disrupts a salt bridge that links Arg229 (blue) to Asp367 (red) within the ␣-tubulin–specific insert
(green). The eight amino acids of the insert stabilize the M loop (purple) of ␣-tubulin.

1997; Asakawa et al., 2006). Because we do not think that the
putative binding site mutations influence microtubule stability, we hypothesize that they alter some other aspect of
tubulin function, such as tubulin folding or subunit flexibility, in Toxoplasma. In budding yeast, alanine scanning mutations in tubulin have been shown to alter folding or other
aspects of subunit function to influence drug resistance or
hypersensitivity and microtubule sensitivity to heat or cold.
For example, altering residues of the GTP binding domain of
␣-tubulin (such as the triple mutation Lys97Ala/Glu98Ala/
Asp99Ala) confers cold sensitivity and benomyl supersensitivity, perhaps as a consequence of altered tubulin folding (Richards
et al., 2000). In contrast, several mutations in yeast ␤-tubulin
(Glu108Ala/Glu111Ala, Glu123Ala, and Arg282Ala/Glu288Ala)
are cold sensitive but benomyl resistant (Reijo et al., 1994).
Ultimately, the significant issue is whether resistant parasites could be sufficiently fit to be spread throughout
natural populations in competition with wild-type parasites in the absence of drug selection. This might be
achieved by high resistance due to multiple mutations or
through multiple mutations that confer resistance but
maintain fitness.
Toxoplasma parasites bearing the N loop mutation
Phe52Tyr have resistance to 7 M oryzalin, but ⬃13% of the
parasite population has overt replication defects, possibly
due to microtubules with increased stability. When this parasite strain was grown in the absence of oryzalin, it spontaneously acquired secondary mutations in the M loop
(Ala273Val) or in an ␣-tubulin-specific insert that stabilizes
the M loop (Asp367Val). The Asp367Val point mutation
eliminates a salt bridge between Asp367 and Arg229. This
salt bridge stabilizes the ␣-tubulin insert, and in turn, the
insert stabilizes the ␣-tubulin M loop (Figure 6C). We expect
that elimination of the salt bridge ultimately decreases the
strength of the ␣-tubulin M loop contact within the protofilament, akin to the action of the Ala273Val mutation, which
is directly in the M loop. We hypothesize that the secondary
mutations increase Toxoplasma fitness by decreasing micro4718

tubule stability. Consistent with this hypothesis, parasites
with the double mutations have both decreased dinitroaniline resistance and decreased incidence of replication defects. It is likely that the Phe52Tyr strain has a high rate of
chromosome segregation defects that provide a strong selective pressure for second site mutations to correct for
tubulin function in the absence of dinitroaniline selection.
Previous work in the fission yeast Schizosaccharomyces pombe
has indicated that tubulin mutations (the ␣-tubulin mutation
Val260Ile) or the loss of the EB-1 homologue MAL3 are
associated with less dynamic microtubules and increased
rates of chromosome loss (Beinhauer et al., 1997; Asakawa et
al., 2006).
Collectively, the results presented in this article suggest
that mutations to ␣1-tubulin confer dinitroaniline resistance
at a cost to microtubule function and parasite fitness. Since a
number of novel mutations confer resistance, it is important
to evaluate whether parasites treated with microtubule-disrupting drugs would rapidly acquire resistance mutations if used
in a therapeutic setting. Studies that have exploited growth
competition assays to assess the fitness of Toxoplasma strains
bearing wild-type or pyrimethamine-resistant dihydrofolate
reductase genes have concluded that even strains that behave identically in vitro can display growth defects in vivo
(Fohl and Roos, 2003). Our dinitroaniline-resistant strains
have overt replication defects in vitro, suggesting that they
have reduced fitness and would fare poorly in similar competition assays. Therefore, drugs that selectively target parasite microtubules remain a compelling option for the development of new antiparasitic therapies.
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